期刊文献+

survivin基因启动子的克隆及其在人喉癌Hep-2细胞中的特异性表达 被引量:3

Molecular cloning of the survivin gene promoter and its specific expression in the human laryngeal cancer Hep-2 cell line
暂未订购
导出
摘要 目的:构建survivin启动子调控的真核表达载体pSurp-EGFP,利用增强型绿色荧光蛋白(EGFP)检测该启动子在Hep-2细胞中的特异表达活性。方法:PCR扩增survivin启动子,置换pShuttle载体中的CMV启动子,构建质粒pSurp;分别双酶切pShuttle、pSurp和pEGFP-C1载体,构建分别携带survivin启动子和巨细胞病毒(CMV)启动子的真核表达载体pCMV-EGFP和pSurp-EGFP;脂质体法转染Hep-2细胞及血管内皮细胞ECV304,荧光显微镜下观察EGFP的表达。结果:成功扩增survivin基因启动子,构建了survivin基因启动子调控的真核表达载体pSurp-EGFP,用其转染两种细胞后,荧光显微镜下见Hep-2细胞发出较强的绿色荧光,而ECV304细胞没有表达。结论:成功克隆survivin启动子,其在Hep-2细胞具有较强的肿瘤特异性启动活性,为进一步开发肿瘤的特异性基因治疗奠定了实验基础。 Objective: To construct the eukaryotic expression vector pSurp-EGFP regulated by the survivin gene promoter and to detect the specific expression of the promoter in human laryngeal cancer Hep- 2 cells by green fluorescent protein assay. Methods : Thesurvivin gene promoter was generated by polymerase chain reaction (PCR) and the CMV promoter of the pShuttle vector replaced by the survivin gene promoter to generate the plasmid pSurp. The three plasmids pShuttle, pSurp and pEGFP-C1 were respectively double-enzyme digested so as to produce the plasmids pCMV-EGFP and pSurp-EGFP carrying the CMV or survivin promoter. The purified pCMV-EGFP and pSurp-EGFP were transfected into Hep-2 cell and vascular endothelial cell ECV304 using liposome transfection reagent and the expressions of EGFP detected by the fluorescent microscope. Results: Thesurvivin gene promoter was successfully cloned by PCR, and thesurvivin gene promoter-regulated pSurp- EGFP was constructed. Green fluorescence wasobserved in Hep-2 cells but not in ECV304. Conclusion : The high specific activity of the survivin gene promoter in Hep-2 cells that we successfully constructed attributes to the studies of tumor specific gene therapy.
出处 《医学研究生学报》 CAS 2008年第6期564-567,I0001,共5页 Journal of Medical Postgraduates
基金 国家自然科学基金资助项目(批准号:30371445)
关键词 SURVIVIN基因 启动子 基因治疗 绿色荧光蛋白 HEP-2 Survivin gene Promoter Gene therapy Green fluorescent protein Hep-2
  • 相关文献

参考文献10

  • 1Nellelbeck DM ,Jerome V, Muller R. Gene therapy : designer promoters for tumor targeting [ J ]. Trends Genel, 2000,16 (4) : 174- 181.
  • 2Scholz IV, Cengic N, Baker Cll,et al. Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer[ J ]. Gene Ther, 2005,12 ( 3 ) : 272-280.
  • 3Jacob D, Davis JJ, Zhang L, et al. Suppression of pancreatic tumor growth in the liver by systemic administration of the TRAIL gene driven by the hTERT promoter [ J ]. Cancer Gene Ther, 2005,12(2) :109-115.
  • 4Schimmer AD. Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice [ J ]. Cancer Res,2004,64 ( 20 ) : 7183-7190.
  • 5Adida C, Crotty PL, McGrath J, et al. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation [ J ]. Am J Pathol, 1998,152 ( 1 ) : 43-49.
  • 6刘江伟,李开宗,窦科峰,马福成,王映梅.胰腺癌组织survivin和COX-2表达的相关性[J].第四军医大学学报,2004,25(7):635-636. 被引量:33
  • 7Konno R,Yamakawa H, Utsunomiya H, et al. Expression of survivin and Bcl-2 in the normal human enomdetrium[ J]. Mol Hum Reprod ,2000,6 (6) :529-534.
  • 8葛京平,魏武,魏威,张征宇,高建平,马驰原.survivin在膀胱癌中的表达及其临床意义[J].医学研究生学报,2006,19(8):716-718. 被引量:9
  • 9陈震球,张喜梅,张振玉,朱净,周庆.环氧化酶-2和survivin在胃癌组织中的表达及其意义[J].医学研究生学报,2007,20(10):1018-1021. 被引量:2
  • 10Kamizono J, Nagano S, Murofushi Y, et al. Survivin-Responsive Conditionally Replicating Adenovirus Exhibits Cancer-Specific and Efficient Viral Replication [ J ]. Cancer Res, 2005, 65 (12) : 5284-5291.

二级参考文献27

共引文献41

同被引文献24

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部